$19.82
At close: Apr 9 EDT
$20.88
1.065.35%
Pre-Market: 6:38 AM EDT
Comments
Loading...
Tonix Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:TNXP | Benzinga
Tonix Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-3.090
Quarterly Revenue Estimate
$2.60M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$10.09M
Analyze the earnings history of Tonix Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TNXP | Tonix Pharmaceuticals | -$576.00 | -$3.09 | — | — | $2.48M | $2.60M | — | — | 05/12/2025 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$2.75K | -$768.00 | -$9.77 | 98.73% | $3.78M | $3.20M | $2.58M | -19.31% | 03/18/2025 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$3.86K | -$293.00 | -$23.00 | 92.15% | $3.99M | $3.08M | $2.82M | -8.38% | 11/12/2024 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$4.92K | -$720.00 | -$1.93K | -167.78% | $0.00 | $3.35M | $2.21M | -34.09% | 08/16/2024 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$10.40K | -$1.25K | -$576.00 | 53.85% | $0.00 | $3.80M | $2.48M | -34.68% | 05/13/2024 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$11.20K | -$5.25K | -$2.75K | 47.56% | $0.00 | $3.83M | $3.78M | -1.33% | 04/01/2024 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$13.79K | -$4.77K | -$5.86K | -22.82% | $0.00 | $5.80M | $3.99M | -31.22% | 11/09/2023 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$24.42K | -$8.80K | -$8.58K | 2.55% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$32.00K | — | -$10.40K | — | $0.00 | — | $0.00 | — | 05/08/2023 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$44.80K | -$17.22K | -$11.20K | 34.94% | $0.00 | — | $0.00 | — | 03/13/2023 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$32.00K | -$20.42K | -$13.79K | 32.45% | $0.00 | — | $0.00 | — | 11/07/2022 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$44.80K | -$29.79K | -$24.42K | 18.05% | $0.00 | — | $0.00 | — | 08/08/2022 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$44.80K | -$32.00K | -$32.00K | 0.00% | $0.00 | — | $0.00 | — | 05/09/2022 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$64.00K | -$38.40K | -$44.80K | -16.67% | $0.00 | — | $0.00 | — | 03/14/2022 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$57.60K | -$44.80K | -$32.00K | 28.57% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$147.20K | -$38.40K | -$44.80K | -16.67% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$236.80K | -$32.00K | -$44.80K | -40.00% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$1.83M | — | -$64.00K | — | $0.00 | — | $0.00 | — | 03/15/2021 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$3.64M | — | -$57.60K | — | $0.00 | — | $0.00 | — | 11/09/2020 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$608.00K | -$140.80K | -$147.20K | -4.55% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| TNXP | Tonix Pharmaceuticals | -$825.60K | — | -$236.80K | — | $0.00 | — | $0.00 | — | 05/12/2020 | Get Alert |
Tonix Pharmaceuticals (TNXP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-18 | $-9.77 | $-768.00 | 98.7 % |
| Q3 | 2024-11-12 | $-23.00 | $-293.00 | 92.2 % |
| Q2 | 2024-08-16 | $-1.93K | $-720.00 | -167.8 % |
| Q1 | 2024-05-13 | $-576.00 | $-1.25K | 53.8 % |
Tonix Pharmaceuticals (TNXP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-18 | $2.58M | $3.20M | -19.3 % |
| Q3 | 2024-11-12 | $2.82M | $3.08M | -8.38 % |
| Q2 | 2024-08-16 | $2.21M | $3.35M | -34.1 % |
| Q1 | 2024-05-13 | $2.48M | $3.80M | -34.7 % |
FAQ
When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?
Tonix Pharmaceuticals (TNXP) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Tonix Pharmaceuticals (NASDAQ:TNXP)?
The Actual EPS was $-9.77, which beat the estimate of $-768.00.
What were Tonix Pharmaceuticals’s (NASDAQ:TNXP) revenues?
The Actual Revenue was $2.6M, which missed the estimate of $3.2M.
Browse earnings estimates, EPS, and revenue on all stocks.